New to Magnet.me? Sign up now to get your own personalised job matches.

Sign up
Logo AtriCure

AtriCure

Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 150,000 implanted to date.

Healthcare
Amsterdam, NL
750 employees

AtriCure

Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 150,000 implanted to date.

Healthcare
Amsterdam, NL
750 employees
Share:
Share:

Find your job or internship faster with a profile.

Sign up now and directly see which opportunities match your preferences.

Opportunities

Interesting to know

This company page was generated automatically and therefore features only limited information. Find out more about AtriCure on their company website:

Logo AtriCure

Interested in working at AtriCure?

When you connect, your chance of being approached for an opportunity at this company is 3 times higher.